NanoViricides, Inc. (NNVC)
1.16
-0.08
(-6.45%)
USD |
NYAM |
Nov 17, 16:00
1.18
+0.02
(+1.72%)
After-Hours: 20:00
NanoViricides Market Cap : 26.69M for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 26.69M |
| November 16, 2026 | 28.53M |
| November 13, 2026 | 28.30M |
| November 12, 2026 | 31.06M |
| November 11, 2026 | 31.75M |
| November 10, 2026 | 32.67M |
| November 09, 2026 | 30.60M |
| November 06, 2026 | 30.37M |
| November 05, 2026 | 29.68M |
| November 04, 2026 | 31.75M |
| November 03, 2026 | 32.90M |
| November 02, 2026 | 31.06M |
| October 30, 2026 | 30.60M |
| October 29, 2026 | 32.90M |
| October 28, 2026 | 33.36M |
| October 27, 2026 | 33.59M |
| October 26, 2026 | 31.29M |
| October 23, 2026 | 32.21M |
| October 22, 2026 | 31.98M |
| October 21, 2026 | 34.74M |
| October 20, 2026 | 34.05M |
| October 19, 2026 | 29.91M |
| October 16, 2026 | 31.75M |
| October 15, 2026 | 31.52M |
| October 14, 2026 | 30.14M |
| Date | Value |
|---|---|
| October 13, 2026 | 30.37M |
| October 12, 2026 | 29.45M |
| October 09, 2026 | 29.91M |
| October 08, 2026 | 30.14M |
| October 07, 2026 | 33.13M |
| October 06, 2026 | 32.21M |
| October 05, 2026 | 33.36M |
| October 02, 2026 | 29.45M |
| October 01, 2026 | 28.99M |
| September 30, 2026 | 29.91M |
| September 29, 2026 | 29.91M |
| September 28, 2026 | 34.51M |
| September 25, 2026 | 33.13M |
| September 24, 2026 | 33.13M |
| September 23, 2026 | 34.74M |
| September 22, 2026 | 33.12M |
| September 21, 2026 | 36.58M |
| September 18, 2026 | 30.74M |
| September 17, 2026 | 30.31M |
| September 16, 2026 | 25.98M |
| September 15, 2026 | 22.73M |
| September 14, 2026 | 22.73M |
| September 11, 2026 | 22.08M |
| September 10, 2026 | 22.08M |
| September 09, 2026 | 22.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.166B |
| Alnylam Pharmaceuticals, Inc. | 20.95B |
| Anika Therapeutics, Inc. | 172.11M |
| Savara, Inc. | 920.80M |
| Arrowhead Pharmaceuticals, Inc. | 6.074B |
Market Cap Related Metrics
| PEG Ratio | -0.4161 |
| Price to Book Value | 4.622 |
| Price | 1.16 |
| Earnings Yield | -46.15% |
| PEGY Ratio | -0.4161 |